A 6-month clinical study to evaluate the effect of a digital disease management tool in patients with T2DM

Trial Identifier: D1841C00004
Sponsor: AstraZeneca
NCTID:: NCT03090464
Start Date: May 2017
Primary Completion Date: May 2018
Study Completion Date: May 2018
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations